Why Curaleaf Stock Was a Winner on Wednesday
And that would be a fine development for Curaleaf and the rest of the ever-struggling marijuana industry. Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position …
Why Curaleaf Got Investors Higher on Friday
One positive internal company development and another outside of its control helped propel Curaleaf (OTC: CURLF) stock into the win column on Friday. The marijuana company’s shares ticked up by 1.5% …
Why Curaleaf Stock Got Smoked on Wednesday
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium …
Prior felon sentenced for defrauding investors out of $400K
In 2006 and 2018, he pleaded guilty to conspiracy to commit mail fraud and bank theft, respectively, for defrauding investors out of over $11.4 million.
Why Curaleaf Holdings Stock Topped the Market Today
Two developments in the medical marijuana segment were encouraging for the pot company. While neither will be a game-changer on its own, they do represent progress for the marijuana sector more …
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
Trump weighs reclassifying marijuana as less dangerous drug, WSJ reports
U.S. President Donald Trump is considering reclassifying marijuana as a less dangerous drug, the Wall Street Journal reported on Friday, citing people familiar with the matter.
Can Cannabis Stocks Reverse Their Prolonged Downtrend?
Cannabis stocks like TLRY and GTBIF remain deep in years-long slump, but U.S. federal reform or global expansion could ignite a long-awaited rebound.
Why Investors Were so High on Curaleaf Stock Thursday
For the quarter, Curaleaf posted total net revenue of more than $314 million, representing a slide from the over $342 million it earned in the same period of 2024. That net loss, meanwhile, was …
Oklahoma cannabis legalization campaign launches for 2026 ballot (Newsletter: August 7, 2025)
Poll: Marijuana consumers expect federal legalization by 2028; Study: Legal dispensaries tied to reduced opioid deaths; Ohio legal sales anniversary Subscribe to receive Marijuana Moment’s newsletter …
7 Best Marijuana Stocks and ETFs to Buy in 2025 – U.S. News
Marijuana Stocks and ETFs. Investing. Money. Home. 7 Best Marijuana Stocks and ETFs to Buy in 2025. In this long-suffering industry, investors continue looking for federal reform. By Matt Whittaker | …
Medical pot pioneer rips ‘un-American’ Hochul, NY regulators for allegedly thwarting businesses: ‘Want to destroy us’
Medical cannabis firms have to pony up money to the state when they want to convert one of their stores for regular adult-use sales — and that figure could hit up to a whopping $15 million …
Why Curaleaf Stock Dropped After Earnings
Curaleaf stock missed ever so slightly on sales last night. Free cash flow declined, but remained positive. Curaleaf has reported positive free cash flow for five quarters running, a rarity among …
Medical marijuana market faces steep new hurdle
New York’s medical marijuana industry, once dominated by major corporate players, is now shrinking—and a new $15 million licensing fee may accelerate its decline, according to Capital Tonight. The …
Cannabis Earnings Show Market Split: US Plant-Touching Stocks Drop, IIPR And Cronos Up
Green Thumb posted Q1 2025 revenue of $248 million, flat year-over-year and sequentially. Gross margin was 48%, down from 52% in Q1 2024. GAAP net income came in at $10 million, down from $9 million a …
Recent Comments